T/CMBA 021-2023
Specification of quality management for ancillary materials present during the production of cellular therapeutic products (English Version)

Standard No.

T/CMBA 021-2023

Language

Chinese, Available in English version

Release Date

2023

Published By

Group Standards of the People's Republic of China

Latest

T/CMBA 021-2023

Scope

This document provides the quality requirements for raw materials used in the production of cell therapy products, as well as the exclusive characteristics and quality requirements for certain components or types of raw materials used in the production, such as serum and serum replacement, recombinant proteins, tissue extracted proteins, etc. .

T/CMBA 021-2023 history

• 2023 T/CMBA 021-2023 Specification of quality management for ancillary materials present during the production of cellular therapeutic products